Ma et al., 2023 - Google Patents
High throughput screening system for engineered cardiac tissuesMa et al., 2023
View HTML- Document ID
- 3728426655191369705
- Author
- Ma M
- Sundaram S
- Lou L
- Agarwal A
- Chen C
- Bifano T
- Publication year
- Publication venue
- Frontiers in Bioengineering and Biotechnology
External Links
Snippet
Introduction: Three dimensional engineered cardiac tissues (3D ECTs) have become indispensable as in vitro models to assess drug cardiotoxicity, a leading cause of failure in pharmaceutical development. A current bottleneck is the relatively low throughput of assays …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Osaki et al. | On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease | |
Yang et al. | High-throughput methods in the discovery and study of biomaterials and materiobiology | |
Mathur et al. | Human iPSC-based cardiac microphysiological system for drug screening applications | |
Thavandiran et al. | Functional arrays of human pluripotent stem cell-derived cardiac microtissues | |
US9857356B2 (en) | Muscle chips and methods of use thereof | |
Ma et al. | High throughput screening system for engineered cardiac tissues | |
Kreutzer et al. | Pneumatic unidirectional cell stretching device for mechanobiological studies of cardiomyocytes | |
Kobuszewska et al. | Heart-on-a-Chip: an investigation of the influence of static and perfusion conditions on cardiac (H9C2) cell proliferation, morphology, and alignment | |
Sonntag et al. | Design and prototyping of a chip-based multi-micro-organoid culture system for substance testing, predictive to human (substance) exposure | |
US10233415B1 (en) | Microfluidics cell culture device | |
Zhao et al. | A multimaterial microphysiological platform enabled by rapid casting of elastic microwires | |
Christensen et al. | 3D printed hydrogel multiassay platforms for robust generation of engineered contractile tissues | |
Miller et al. | Rapid 3D BioPrinting of a human iPSC-derived cardiac micro-tissue for high-throughput drug testing | |
Ji et al. | Improved resolution and fidelity of droplet-based bioprinting by upward ejection | |
Wei et al. | Microfluidics-enabled 96-well perfusion system for high-throughput tissue engineering and long-term all-optical electrophysiology | |
Shinde et al. | Recent advances of biosensor-integrated organ-on-a-chip technologies for diagnostics and therapeutics | |
Agrawal et al. | Devices and techniques used to obtain and analyze three‐dimensional cell cultures | |
Peel et al. | Imaging microphysiological systems: A review | |
Koch et al. | Tissue barrier-on-chip: a technology for reproducible practice in drug testing | |
Chen et al. | Engineering Cardiac Tissue for Advanced Heart‐On‐A‐Chip Platforms | |
Wu et al. | Automated fabrication of a scalable heart-on-a-chip device by 3D printing of thermoplastic elastomer nanocomposite and hot embossing | |
Rimann et al. | 3D bioprinted muscle and tendon tissues for drug development: Biotechnet Switzerland | |
Branco et al. | From human pluripotent stem cells to 3D Cardiac microtissues: progress, applications and challenges | |
Murata et al. | Systems for the functional evaluation of human heart tissues derived from pluripotent stem cells | |
Podlipec et al. | Cell-scaffold adhesion dynamics measured in first seconds predicts cell growth on days scale–optical tweezers study |